Analysis of the publicly available dataset revealed that the level of mRNA of PHLDA1 is positively correlated with survival of neuroblastoma patients with MYCN-amplification, but no significant correlation was found for the larger group of patients with MYCN-non-amplified status in the analyzed dataset. The gene discussed is PHLDA1; the disease is neuroblastoma.